• Publications
  • Influence
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
TLDR
The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported. Expand
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
TLDR
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit. Expand
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
TLDR
The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity. Expand
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
TLDR
Patients with cancer and COVID-19 who were admitted to hospital had a high case-fatality rate and unfavourable prognostic factors, including receiving chemotherapy within 4 weeks before symptom onset and male sex, might help clinicians to identify patients at high risk of fatal outcomes. Expand
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions
TLDR
Based on literature search and interviews with some HCP working at Wuhan, capital city of Hubei, some of the effective measures taken to reduce infection among HCP are summarized, and suggestions for improving occupational safety during an infectious disease outbreak are made. Expand
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure
TLDR
Aged patients with lower ROX index, thrombocytopenia, and elevated IL-6 values are at increased risk of HFNC failure, and early stratified COVID-19 patients with HFNC therapy into relevant risk categories are stratified. Expand
Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
TLDR
Evaluated the characteristics of T‐cell responses associated with PP to assess the importance of T cells for viral control in SARS‐CoV‐2 pandemic. Expand
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients
TLDR
This study revealed that a high number of patients with COVID-19 developed DVT, particularly in critically ill patients with high D-dimer levels who required no anticoagulant medication. Expand
High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients
TLDR
The findings indicated viral replication in extrapulmonary sites should be monitored intensively during antiviral therapy after severe COVID-19 patients in the LOTUS China trial. Expand
Tracheostomy in 80 COVID-19 Patients: A Multicenter, Retrospective, Observational Study
TLDR
In patients with SARS-CoV-2 pneumonia, tracheostomies were feasible to conduct by ICU physician at bedside with few major complications and were associated with an increased mortality rate. Expand
...
1
2
3
...